Top

Published in:

01-05-2014 | Review

Bone metabolism in the fetus and neonate

Author: Christopher S. Kovacs

Published in: Pediatric Nephrology | Issue 5/2014

Abstract

During embryonic development most of the skeleton begins as a cartilaginous scaffold that is progressively resorbed and replaced by bone. Such endochondral bone development does not cease until the growth plates fuse during puberty. Growth and mineralization of the skeleton are dependent upon the adequate delivery of mineral. During fetal development, the placenta actively transports calcium, magnesium and phosphorus from the maternal circulation. After birth, the role of mineral transport is assumed by the intestines. The limited data currently available on fetal humans are largely based on cord blood samples from normal fetuses and pathological specimens from fetuses which died in utero or at birth. Consequently, much of our understanding of the regulation of fetal mineral and bone homeostasis comes from the study of animal fetuses that have been manipulated surgically, pharmacologically and genetically. Animal and human data indicate that fetal mineral homeostasis requires parathyroid hormone (PTH) and PTH-related protein—but not vitamin D/calcitriol, calcitonin or sex steroids. In the days to weeks after birth, intestinal calcium absorption becomes an active process, which necessitates that the infant depends upon vitamin D/calcitriol. However, even this postnatal function of calcitriol can be bypassed by increasing the calcium content of the diet or by administering calcium infusions.

Kovacs CS (2011) Fetal mineral homeostasis. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone: Biology and diseases, 2nd edn. Elsevier/Academic Press, San Diego, pp 247–275

Kovacs CS (2011) Fetus, Neonate and Infant. In: Feldman D, Pike WJ, Adams JS (eds) Vitamin D, 3rd edn. Academic, New York, pp 625–646CrossRef

Kovacs CS (2012) The role of vitamin d in pregnancy and lactation: insights from animal models and clinical studies. Annu Rev Nutr 32:97–123PubMedCrossRef

Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE, Kronenberg HM (1998) Regulation of murine fetal–placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 101:2812–2820PubMedCentralPubMedCrossRef

Kovacs CS, Woodland ML, Fudge NJ, Friel JK (2005) The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer. Am J Physiol Endocrinol Metab 289:E133–E144PubMedCrossRef

Kovacs CS, Chafe LL, Woodland ML, McDonald KR, Fudge NJ, Wookey PJ (2002) Calcitropic gene expression suggests a role for intraplacental yolk sac in maternal-fetal calcium exchange. Am J Physiol Endocrinol Metab 282:E721–E732PubMed

Suzuki Y, Kovacs CS, Takanaga H, Peng JB, Landowski CP, Hediger MA (2008) Calcium TRPV6 is involved in murine maternal–fetal calcium transport. J Bone Miner Res 23:1249–1256PubMedCentralPubMedCrossRef

Yang Y (2009) Skeletal morphogenesis during embryonic development. Crit Rev Eukaryot Gene Expr 19:197–218PubMedCrossRef

Simmonds CS, Karsenty G, Karaplis AC, Kovacs CS (2010) Parathyroid hormone regulates fetal–placental mineral homeostasis. J Bone Miner Res 25:594–605PubMedCrossRef

10.

Kovacs CS, Manley NR, Moseley JM, Martin TJ, Kronenberg HM (2001) Fetal parathyroids are not required to maintain placental calcium transport. J Clin Invest 107:1007–1015PubMedCentralPubMedCrossRef

11.

Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM (1996) Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci USA 93:15233–15238PubMedCentralPubMedCrossRef

12.

Kovacs CS, Chafe LL, Fudge NJ, Friel JK, Manley NR (2001) PTH regulates fetal blood calcium and skeletal mineralization independently of PTHrP. Endocrinology 142:4983–4993PubMedCrossRef

13.

Manley NR, Capecchi MR (1995) The role of Hoxa-3 in mouse thymus and thyroid development. Development 121:1989–2003PubMed

14.

Bond H, Dilworth MR, Baker B, Cowley E, Requena Jimenez A, Boyd RD, Husain SM, Ward BS, Sibley CP, Glazier JD (2008) Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice. J Physiol 586:2015–2025PubMedCentralPubMedCrossRef

15.

Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF (1996) Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76:127–173PubMed

16.

Riddle RC, Macica CM, Clemens TL (2008) Vascular, cardiovascular, and neurologic actions of parathyroid-related protein. In: Bilezikian JP, Raisz LG, Martin TJ (eds) Principles of bone biology, 3rd edn. Academic, New York, pp 733–748CrossRef

17.

Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ (1996) Indian hedgehog and parathyroid hormone-related protein regulate the rate of cartilage differentiation. Science 273:613–622PubMedCrossRef

18.

Karsenty G, Kronenberg HM, Settembre C (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629–648PubMedCrossRef

19.

Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277–289PubMedCrossRef

20.

Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize L, Ho C, Abou-Samra AB, Jüppner H, Segre GV, Kronenberg HM (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663–666PubMedCrossRef

21.

Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE (1996) Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240–10245PubMedCentralPubMedCrossRef

22.

Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg HM, Jüppner H (1997) Targeted expression of constitutively active PTH/PTHrP receptors delays endochondral bone formation and rescues PTHrP-less mice. Proc Natl Acad Sci USA 94:13689–13694PubMedCentralPubMedCrossRef

23.

Lanske B, Divieti P, Kovacs CS, Pirro A, Landis WJ, Krane SM, Bringhurst FR, Kronenberg HM (1998) The parathyroid hormone/parathyroid hormone-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139:5192–5204

24.

Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34. J Clin Invest 115:2402–2411PubMedCentralPubMedCrossRef

25.

Rubin LP, Kovacs CS, De Paepe ME, Tsai SW, Torday JS, Kronenberg HM (2004) Arrested pulmonary alveolar cytodifferentiation and defective surfactant synthesis in mice missing the gene for parathyroid hormone-related protein. Dev Dyn 230:278–289PubMedCrossRef

26.

Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, Blom E, Gillerot Y, Weigel JF, Kruger G, Hiort O, Seemann P, Mundlos S (2010) Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 86:434–439PubMedCentralPubMedCrossRef

27.

Miao D, He B, Karaplis AC, Goltzman D (2002) Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109:1173–1182PubMedCentralPubMedCrossRef

28.

Farrugia W, de Gooyer T, Rice GE, Moseley JM, Wlodek ME (2000) Parathyroid hormone(1–34) and parathyroid hormone-related protein(1–34) stimulate calcium release from human syncytiotrophoblast basal membranes via a common receptor. J Endocrinol 166:689–695PubMedCrossRef

29.

Karaplis AC, He B, Nguyen MT, Young ID, Semeraro D, Ozawa H, Amizuka N (1998) Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 139:5255–5258PubMedCrossRef

30.

Oostra RJ, van der Harten JJ, Rijnders WP, Scott RJ, Young MP, Trump D (2000) Blomstrand osteochondrodysplasia: three novel cases and histological evidence for heterogeneity. Virchows Arch 436:28–35PubMedCrossRef

31.

McDonald KR, Fudge NJ, Woodrow JP, Friel JK, Hoff AO, Gagel RF, Kovacs CS (2004) Ablation of calcitonin/calcitonin gene related peptide-a impairs fetal magnesium but not calcium homeostasis. Am J Physiol Endocrinol Metab 287:E218–E226PubMedCrossRef

32.

Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509–514PubMedCentralPubMedCrossRef

33.

Halloran BP, De Luca HF (1981) Effect of vitamin D deficiency on skeletal development during early growth in the rat. Arch Biochem Biophys 209:7–14PubMedCrossRef

34.

Miller SC, Halloran BP, DeLuca HF, Jee WS (1983) Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int 35:455–460PubMedCrossRef

35.

Brommage R, DeLuca HF (1984) Placental transport of calcium and phosphorus is not regulated by vitamin D. Am J Physiol 246:F526–F529PubMed

36.

Lachenmaier-Currle U, Harmeyer J (1989) Placental transport of calcium and phosphorus in pigs. J Perinat Med 17:127–136PubMedCrossRef

37.

Glazier JD, Mawer EB, Sibley CP (1995) Calbindin-D_9K gene expression in rat chorioallantoic placenta is not regulated by 1,25-dihydroxyvitamin D₃. Pediatr Res 37:720–725PubMedCrossRef

38.

Marche P, Delorme A, Cuisinier-Gleizes P (1978) Intestinal and placental calcium-binding proteins in vitamin D-deprived or -supplemented rats. Life Sci 23:2555–2561PubMedCrossRef

39.

Verhaeghe J, Thomasset M, Brehier A, Van Assche FA, Bouillon R (1988) 1,25(OH)₂D₃ and Ca-binding protein in fetal rats: relationship to the maternal vitamin D status. Am J Physiol 254:E505–E512PubMed

40.

Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 98:7498–7503PubMedCentralPubMedCrossRef

41.

Dardenne O, Prud’homme J, Arabian A, Glorieux FH, St-Arnaud R (2001) Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135–3141PubMed

42.

Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391–4396PubMed

43.

Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831–9835PubMedCentralPubMedCrossRef

44.

Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982–4987PubMed

45.

Dardenne O, Prudhomme J, Hacking SA, Glorieux FH, St-Arnaud R (2003) Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 18:637–643PubMedCrossRef

46.

Maxwell JP, Miles LM (1925) Osteomalacia in China. J Obstet Gynaecol Br Empire 32:433–473CrossRef

47.

Pereira GR, Zucker AH (1986) Nutritional deficiencies in the neonate. Clin Perinatol 13:175–189PubMed

48.

Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 160:491–497PubMedCrossRef

49.

Mohapatra A, Sankaranarayanan K, Kadam SS, Binoy S, Kanbur WA, Mondkar JA (2003) Congenital rickets. J Trop Pediatr 49:126–127PubMedCrossRef

50.

Innes AM, Seshia MM, Prasad C, Al Saif S, Friesen FR, Chudley AE, Reed M, Dilling LA, Haworth JC, Greenberg CR (2002) Congenital rickets caused by maternal vitamin D deficiency. Paediatr Child Health 7:455–458PubMedCentralPubMed

51.

Begum R, Coutinho ML, Dormandy TL, Yudkin S (1968) Maternal malabsorption presenting as congenital rickets. Lancet 1:1048–1052PubMedCrossRef

52.

Congdon P, Horsman A, Kirby PA, Dibble J, Bashir T (1983) Mineral content of the forearms of babies born to Asian and white mothers. Br Med J (Clin Res Ed) 286:1233–1235CrossRef

53.

Sann L, David L, Thomas A, Frederich A, Chapuy MC, Francois R (1976) Congenital hyperparathyroidism and vitamin D deficiency secondary to maternal hypoparathyroidism. Acta Paediatr Scand 65:381–385PubMedCrossRef

54.

Weiler HA, Fitzpatrick-Wong SC, Schellenberg JM (2008) Bone mass in First Nations, Asian and white newborn infants. Growth Dev Aging 71:35–43PubMed

55.

Brooke OG, Brown IR, Bone CD, Carter ND, Cleeve HJ, Maxwell JD, Robinson VP, Winder SM (1980) Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 280:751–754PubMedCentralPubMedCrossRef

56.

Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL (2011) Vitamin D supplementation during pregnancy: double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 26:2341–2357PubMedCentralPubMedCrossRef

57.

Morley R, Carlin JB, Pasco JA, Wark JD (2006) Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 91:906–912PubMedCrossRef

58.

Mahon P, Harvey N, Crozier S, Inskip H, Robinson S, Arden N, Swaminathan R, Cooper C, Godfrey K (2010) Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 25:14–19PubMedCrossRef

59.

Viljakainen HT, Saarnio E, Hytinantti T, Miettinen M, Surcel H, Makitie O, Andersson S, Laitinen K, Lamberg-Allardt C (2010) Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 95:1749–1757PubMedCrossRef

60.

Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C (2006) Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 367:36–43PubMedCrossRef

61.

Kovacs CS (2012) Fetal control of calcium and phosphate homeostasis—lessons from mouse models. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T (eds) Genetics of bone biology and skeletal disease. Academic Press/Elsevier, San Diego, pp 205–220

Title: Bone metabolism in the fetus and neonate
Author: Christopher S. Kovacs
Publication date: 01-05-2014
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 5/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-013-2461-4

At a glance: The STEP trials

Springer Medicine

Bone metabolism in the fetus and neonate

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2014

Nephrotic syndrome complicated by idiopathic central diabetes insipidus

Strategies for the preservation of residual renal function in pediatric dialysis patients

Erratum to: Steroid-resistant nephrotic syndrome in a child with dysmorphic features: Questions

Draining the edema: a new role for aquaretics?

Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience

Erratum to: Steroid-resistant nephrotic syndrome in a child with dysmorphic features: Answers